Related Experiment Video
Updated: Jul 1, 2025

Murine Bioluminescent Hepatic Tumour Model
Published on: July 17, 2010
Hepatomegaly and jaundice as the presenting symptoms of systemic light-chain amyloidosis: A case report
Xu Zhang1,2, Fei Tang1,2, Yan-Ying Gao1
1Department of Gastroenterology and Hepatology, The Third Central Hospital of Tianjin, Tianjin 300170, China.
Background:
Light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by the pathologic production and extracellular tissue deposition of fibrillar proteins derived from immunoglobulin AL fragments secreted by a clone of plasma cells, which leads to progressive dysfunction of the affected organs. The two most commonly affected organs are the heart and kidneys, and liver is rarely the dominant affected organ with only 3.9% of cases, making them prone to misdiagnosis and missed diagnosis.
Case Summary:
A 65-year-old woman was admitted with a 3-mo history of progressive jaundice and marked hepatomegaly. Initially, based on enhanced computed tomography scan and angiography, Budd-Chiari syndrome was considered and balloon dilatation of significant hepatic vein stenoses was performed. However, additional diagnostic procedures, including liver biopsy and bone marrow-examination, revealed immunoglobulin kapa AL amyloidosis with extensive liver involvement and hepatic vascular compression. The disease course was progressive and fatal, and the patient eventually died 5 mo after initial presentation of symptoms.
Conclusion:
AL amyloidosis with isolated liver involvement is very rare, and can be easily misdiagnosed as a vascular disease.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Lysosomal Hydrolases

